VectorY
Dr. Marco Boorsma has a proven track record of building and operationally leading biotech companies. He is an experienced VC professional with a background in business development and science, and board member of several drug development companies. Marco is also General Partner at Forbion.
This person is not in the org chart
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.